Loading clinical trials...
Loading clinical trials...
A single-center prospective study. Patients undergoing minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden are eligible. Femoral cannulation was performed percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA; Teleflex/Essential Medical, Malvern, PA). Data regarding preoperative clinical characteristics and operative details were obtained by medical records review.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Karolinska University Hospital
Stockholm, Sweden
Start Date
August 1, 2017
Primary Completion Date
December 1, 2022
Completion Date
December 1, 2022
Last Updated
July 18, 2022
600
ESTIMATED participants
Percutaneous vascular closure
DEVICE
Lead Sponsor
Karolinska University Hospital
NCT04795193
NCT05038111
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions